​

Wave Life Sciences Ownership | Who Owns Wave Life Sciences?

OverviewForecastRevenueFinancialsChartTranscripts

Wave Life Sciences Ownership Summary

Wave Life Sciences is owned by 25.06% institutional investors, 16.30% insiders, and 58.63% retail investors. Ra capital management is the largest institutional shareholder, holding 13.85% of WVE shares. BB Biotech AG Ord is the top mutual fund, with 2.68% of its assets in Wave Life Sciences shares.

WVE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockWave Life Sciences25.06%16.30%58.63%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management18.20M13.85%$225.16M
Adage capital partners gp9.62M7.32%$119.03M
Blackrock funding, inc. /de9.36M7.12%$115.79M
Maverick capital8.26M6.28%$102.19M
Blackrock6.74M5.21%$33.63M
M28 capital management lp5.66M4.31%$70.07M
Price t rowe associates inc /md/5.10M3.88%$63.07M
Kynam capital management, lp4.90M3.73%$60.61M
Artal group4.57M3.53%$22.79M
Bellevue group4.09M3.11%$50.65M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
M28 capital management lp5.66M68.79%$70.07M
Kynam capital management, lp4.90M3.58%$60.61M
Ra capital management18.20M3.00%$225.16M
683 capital management3.79M2.90%$46.82M
Bioimpact capital1.49M2.62%$18.42M
Affinity asset advisors1.50M2.49%$18.55M
Stempoint capital lp721.21K2.23%$8.92M
Siren3.75M2.05%$46.39M
Maverick capital8.26M1.84%$102.19M
Silverarc capital management608.90K1.65%$7.53M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de9.36M0.00%2.06M
Price t rowe associates inc /md/5.10M0.01%1.97M
Pfizer1.88M0.89%1.88M
Loomis sayles & co l p1.66M0.03%1.66M
Bioimpact capital1.49M2.62%864.77K

Top Sellers

HolderShares% AssetsChange
Siren3.75M2.05%-1.97M
Maverick capital8.26M1.84%-1.79M
Takeda pharmaceutical---1.35M
Maven securities170.00K0.05%-680.00K
Ikarian capital---544.26K

New Positions

HolderShares% AssetsChangeValue
Pfizer1.88M0.89%1.88M$23.19M
Loomis sayles & co l p1.66M0.03%1.66M$20.55M
Voloridge investment management845.83K0.04%845.83K$10.46M
F/m investments226.03K0.10%226.03K$2.80M
Eam investors214.72K0.38%214.72K$2.66M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Allworth financial lp-3.00
Nelson, van denburg & campbell wealth management group-12.00
Capital performance advisors llp-13.00
Global retirement partners-85.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202481-50.61%32,943,703-72.58%250.31%57-40.00%14-64.10%
Sep 30, 202416310.88%118,791,97226.74%891.71%9515.85%39-15.22%
Jun 30, 20241479.70%93,731,2242.54%721.45%82-6.82%4643.75%
Mar 31, 202413413.56%91,412,7220.25%701.02%882.33%32190.91%
Dec 31, 202311835.63%91,181,37025.54%831.77%86120.51%11-60.71%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BB Biotech AG Ord4.09M2.68%-
iShares Russell 2000 ETF2.53M1.65%-21.89K
PRIMECAP Odyssey Aggressive Growth2.45M1.61%-72.38K
Vanguard Institutional Extnd Mkt Idx Tr1.80M1.18%2.70K
US Small-Cap Growth II Equity Comp1.64M1.07%834.58K
T. Rowe Price New Horizons1.64M1.07%-
Loomis Sayles Small Cap Growth Instl1.42M0.92%247.21K
Artisan International Small-Mid Investor1.27M0.83%-
Artisan Non-U.S. Small-Mid Growth Comp1.27M0.83%-
T. Rowe Price Health Sciences1.21M0.79%-120.90K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 20, 2025HENRY CHRISTIAN O-Sell$102.57K
Mar 07, 2025BOLNO PAUL President and CEOSell$1.62M
Nov 25, 2024BOLNO PAUL President and CEOSell$750.00K
Nov 15, 2024BOLNO PAUL President and CEOSell$733.67K
Nov 08, 2024Francis Chris See RemarksSell$576.00K

Insider Transactions Trends

DateBuySell
2025 Q1-2
2024 Q4-8
2024 Q312
2024 Q2-1
2024 Q1--

WVE Ownership FAQ

Who Owns Wave Life Sciences?

Wave Life Sciences shareholders are primarily institutional investors at 25.06%, followed by 16.30% insiders and 58.64% retail investors. The average institutional ownership in Wave Life Sciences's industry, Biotech Stocks , is 68.48%, which Wave Life Sciences falls below.

Who owns the most shares of Wave Life Sciences?

Wave Life Sciences’s largest shareholders are Ra capital management (18.2M shares, 13.85%), Adage capital partners gp (9.62M shares, 7.32%), and Blackrock funding, inc. /de (9.36M shares, 7.12%). Together, they hold 28.29% of Wave Life Sciences’s total shares outstanding.

Does Blackrock own Wave Life Sciences?

Yes, BlackRock owns 5.21% of Wave Life Sciences, totaling 6.74M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 33.63M$. In the last quarter, BlackRock increased its holdings by 363.48K shares, a 5.70% change.

Who is Wave Life Sciences’s biggest shareholder by percentage of total assets invested?

M28 capital management lp is Wave Life Sciences’s biggest shareholder by percentage of total assets invested, with 68.79% of its assets in 5.66M Wave Life Sciences shares, valued at 70.07M$.

Who is the top mutual fund holder of Wave Life Sciences shares?

BB Biotech AG Ord is the top mutual fund holder of Wave Life Sciences shares, with 2.68% of its total shares outstanding invested in 4.09M Wave Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools